ERBB2 and breast carcinoma: Among women with HER2+ breast cancer, those in the highest vs. lowest tertile of triglycerides had an 86% reduced overall mortality risk (HR 0.14, 95% CI 0.03–0.60, p-trend 0.038) (Additional file 4: Table S2).